Trial intelligence / Profile preview

Voucher vs. Direct Mailing of Nicotine Patches to Quitline Smokers

NCT01736085Phase 3Completed

Sponsor
University of California, San Diego
Start
Apr 2013
Primary completion
Nov 2014
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (6 arms), sponsored by University of California, San Diego. Primary endpoint: Number of Participants With Six Months Prolonged Abstinence at 7 months. Started Apr 2013; status: completed.

02

Drugs

nicotine patch
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT01736085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01736085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call